Article Text
PDF
Statistics from Altmetric.com
Q Is modafinil an effective treatment for attention deficit hyperactivity disorder (ADHD) in young people?
METHODS
Design:
Multicentre randomised controlled trial.
Allocation:
Unclear.
Blinding:
Double blind.
Follow up period:
9 weeks.
Setting:
24 sites in the USA. Recruitment: November 2003 to June 2004.
Patients:
246 young people (aged 6–17 years) with moderate or worse ADHD (Clinical Global Impression of Severity of Illness (CGI-S) rating ⩾4); above normal score on ADHD Rating Scale-IV (ADHD-RS-IV) School Version (⩾1.5 SD above age and gender norms; IQ ⩾80 (Wechsler Intelligence Scale). Exclusions: previous or current significant psychiatric disorder or active clinical comorbidities; current successfully managed ADHD; ADHD non-responsive to at least two previous treatments with stimulant …
Footnotes
For correspondence: Dr Joseph Biederman, Pediatric Psychopharmacology Research Unit, Massachusetts General Hospital, Yawkey Center for Outpatient Care, Boston, MA 02114, USA; jbiederman{at}partners.org
Source of funding: Cephalon, Inc.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.